Baxter Files Complaint with U.S. International Trade Commission Over Patent Infringement

Summary

Baxter International Inc. has filed a complaint with the U.S. International Trade Commission alleging that certain foreign companies are infringing on four U.S. patents related to hemostatic products. The complaint seeks an investigation and potential exclusion order to protect Baxter's intellectual property.